KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Depreciation and Depletion (2016 - 2026)

CRISPR Therapeutics AG (CRSP) has disclosed Depreciation and Depletion for 11 consecutive years, with $5.6 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion rose 16.67% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.3 million through Dec 2025, up 0.52% year-over-year, with the annual reading at $19.4 million for FY2025, 1.04% up from the prior year.
  • Depreciation and Depletion hit $5.6 million in Q4 2025 for CRISPR Therapeutics AG, up from $4.4 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $7.3 million in Q2 2022 to a low of $2.7 million in Q1 2021.
  • Historically, Depreciation and Depletion has averaged $5.0 million across 5 years, with a median of $4.9 million in 2023.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 148.0% in 2021 and later tumbled 31.51% in 2023.
  • Year by year, Depreciation and Depletion stood at $6.2 million in 2021, then dropped by 6.45% to $5.8 million in 2022, then dropped by 15.52% to $4.9 million in 2023, then fell by 2.04% to $4.8 million in 2024, then rose by 16.67% to $5.6 million in 2025.
  • Business Quant data shows Depreciation and Depletion for CRSP at $5.6 million in Q4 2025, $4.4 million in Q3 2025, and $4.6 million in Q2 2025.